[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-349249-105":59,"doc-detail-349249-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","cdc6thbs1-accelerates-pancreatic-cancer-progression-via-akt-mediated-glycolytic-reprogramming","CDC6/THBS1 accelerates pancreatic cancer progression via AKT-mediated glycolytic reprogramming","","Pancreatic cancer shows early metastatic spread and intrinsic resistance to chemotherapy, leading to poor outcomes. Cell Division Cycle 6 (CDC6) has roles in DNA replication licensing, yet its function in pancreatic cancer remains unclear. Using TCGA RNA-seq and expression profiling, the study links elevated CDC6 with worse patient prognosis. Functional assays demonstrate CDC6 drives proliferation, migration, and invasion, while THBS1 correlates with CDC6 and is enriched in glucose metabolism. Mechanistically, CDC6 cooperates with E2F1 to promote THBS1 transcription and activates AKT signaling, enhancing glycolysis and tumor progression; THBS1 knockdown reverses these effects. The CDC6/THBS1/AKT axis emerges as a therapeutic target.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/cdc6thbs1-accelerates-pancreatic-cancer-progression-via-akt-mediated-glycolytic-reprogramming/349249/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/cdc6thbs1-accelerates-pancreatic-cancer-progression-via-akt-mediated-glycolytic-reprogramming/349249.png","ImageObject",300,407,{"name":92,"@type":93},"McQueen","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-24","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",11,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"What relationship does the study identify between CDC6 expression and pancreatic cancer outcomes?","Question",{"text":113,"@type":114},"CDC6 expression is upregulated in pancreatic cancer and its higher level correlates with unfavorable patient prognosis.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"How does CDC6 affect pancreatic cancer cell behavior and metabolism?",{"text":118,"@type":114},"CDC6 promotes proliferation, migration, and invasion and enhances glycolysis through changes in glucose-related metabolic activity.",{"name":120,"@type":111,"acceptedAnswer":121},"What role does THBS1 play in CDC6-driven tumor progression?",{"text":122,"@type":114},"THBS1 is positively correlated with CDC6 expression; CDC6 facilitates THBS1 transcription, and THBS1 knockdown abrogates CDC6-associated pro-tumor effects.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},349249,1790126720,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":140,"language":141,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":67,"update_tm":145,"read_time":146,"preview_page_count":19,"preview_urls":147},5909890329169,"https://ap-avatar.wpscdn.com/davatar_9964176cb1d06d4a9deccf72a44ae3dc","[www.nature.com/cddis](www.nature.com/cddis)  \nARTICLE OPEN   \nCDC6/THBS1 accelerates pancreatic cancer progression via AKT-mediated glycolytic reprogramming  \n 1,2,4, Xi Chen1,2,4, Ziyu Liu1,3, Chongyu Wang 1,2, Tianyu Chen 1,2 and Jinhui Zhu 2 ✉  \nMengqiu Yin  \n© The Author(s) 2026  \n\n|  |  |  |\n| --- | --- | --- |\n|  | Pancreatic cancer remains one of the most aggressive malignancies, characterized by early metastatic spread and intrinsic resistance to chemotherapy, which ultimately results in poor treatment outcomes. While the Cell Division Cycle 6 (CDC6) protein has been extensively characterized across multiple cancer types, its functional role in the pathogenesis of pancreatic cancer remains poorly understood. In this study, we performed bioinformatics analysis using RNA-seq data from The Cancer Genome Atlas (TCGA) pancreatic adenocarcinoma cohort, and identiﬁed differentially expressed genes through microarray proﬁling. We conducted a comprehensive functional characterization of CDC6 using CCK-8, colony formation, wound healing, Transwell assays, and ﬂow cytometry, and assessed cellular glycolysis levels based on measurements of ATP production, lactic acid generation, and glucose content. Subcutaneous xenograft mouse models were established to evaluate the impact of CDC6 on tumor growth in vivo, while mechanistic investigations were carried out using co-immunoprecipitation, chromatin immunoprecipitation, dual-luciferase reporter assays, and nucleocytoplasmic fractionation. Our results revealed that CDC6 expression is upregulated in pancreatic cancer, and its elevated expression is signiﬁcantly correlated with unfavorable patient prognosis. Functional experiments demonstrated that CDC6 promotes the proliferation, migration, and invasion of pancreatic cancer cells. Thrombospondin 1 (THBS1) was identiﬁed to be positively correlated with CDC6 expression, and differentially expressed genes were notably enriched in the glucose metabolism pathway. Mechanistically, CDC6 cooperates with E2F1 to facilitate the transcription of THBS1, and the AKT signaling pathway is activated via the CDC6/THBS1 interaction. Overexpression of CDC6 signiﬁcantly promoted glycolysis and tumor progression in pancreatic cancer, whereas these pro-tumor effects were markedly abrogated by THBS1 knockdown. Collectively, our ﬁndings demonstrate that CDC6/THBS1/AKT signaling drives glycolysis and accelerates pancreatic cancer progression, suggesting |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  | that the CDC6/THBS1/AKT axis may serve as a promising therapeutic target for pancreatic cancer. |  |\n|  |  |  |\n|  |  |  |\n|  | Cell Death and Disease (2026)17:524; [https://doi.org/10.1038/s41419-026-08758-2](https://doi.org/10.1038/s41419-026-08758-2) |  |\n|  |  |  |\n\nINTRODUCTION  \nPancreatic cancer is one of the most aggressive and lethal malignancies, characterized by rapid progression and dismal prognosis [1, 2] . Globally representing the 11th most prevalent cancer diagnosis, it disproportionately accounts for nearly 5% of cancer-related mortality, currently ranking as the sixth leading cause of cancer deaths worldwide [3] . This grim outlook stems principally from diagnostic challenges—a majority of patients present with locally advanced or metastatic disease at initial diagnosis due to the organ’s deep anatomical location and insidious symptom onset [4] . Surgical resection with adjuvant chemotherapy remains the cornerstone of curative treatment, yet only 15–20% of newly diagnosed patients meet resectability criteria [5, 6] . Alarmingly, 75% of surgically treated patients develop recurrence within 24 months post-intervention [7] . For patients who are not candidates for surgical intervention, gemcitabine-based chemotherapy remains the standard ﬁrst-line treatment; however, the development of drug resistance po","cbCaiu3RpmI4Uiu3","https://ap.wps.com/l/cbCaiu3RpmI4Uiu3","pdf",11695789,17,"English","# INTRODUCTION\n## Background and clinical challenges\n## CDC6 biology and rationale for the study","[{\"question\":\"What relationship does the study identify between CDC6 expression and pancreatic cancer outcomes?\",\"answer\":\"CDC6 expression is upregulated in pancreatic cancer and its higher level correlates with unfavorable patient prognosis.\"},{\"question\":\"How does CDC6 affect pancreatic cancer cell behavior and metabolism?\",\"answer\":\"CDC6 promotes proliferation, migration, and invasion and enhances glycolysis through changes in glucose-related metabolic activity.\"},{\"question\":\"What role does THBS1 play in CDC6-driven tumor progression?\",\"answer\":\"THBS1 is positively correlated with CDC6 expression; CDC6 facilitates THBS1 transcription, and THBS1 knockdown abrogates CDC6-associated pro-tumor effects.\"}]","CDC6/THBS1 accelerates pancreatic cancer progression via AKT-mediated glycolytic reprogramming | PDF",1790082435,43,[148,152,156,160],{"page_no":8,"url":149,"width":150,"height":151},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d828f0b5b51eb716217e01b3310e9e63.webp",983,1305,{"page_no":14,"url":153,"width":154,"height":155},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c08e85f50453f33937892e65a22511a4.webp",982,1304,{"page_no":81,"url":157,"width":158,"height":159},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/7f8804088aee8fdcba68d3e81ade763b.webp",981,1303,{"page_no":19,"url":161,"width":162,"height":163},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d3a145785aa7d90f8759e8569368fcac.webp",980,1301]